In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

View Content for:
Display:
  •          
Help with display options.
Results 1-25 of 25 for your search:
Drug:  vismodegib
Find trials that include:  Any drugs shown
Trial Status:  Closed
Start Over
        Show
1.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2010-01737, CDR0000670590, 2009-0473, 8384, U01CA062491, U01CA062461, P30CA016672, MDA-2009-0473, NCT01163084

2.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: SHH4429g, NCT00636610

3.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: SHH4489g, NCT00739661

4.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: SHH4476g, GO01541, NCT00833417

5.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2011-01917, ECOG-E1508, CDR0000640898, E1508, U10CA021115, NCT00887159

6.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 22 and over
Sponsor: NCI
Protocol IDs: NCI-2012-03020, PBTC-025B, U01CA081457, NCT00939484

7.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 35 to 75
Sponsor: Other
Protocol IDs: 2009-026, SHH-4685s, NCT00957229

8.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2012-02922, CDR0000654829, ABTC-0904, U01CA137443, 0904, NCT00980343

9.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2011-01425, 09-0356, CDR0000655339, NYU 09-0356, 8376, N01CM00070, N01CM00071, N01CM00038, P30CA016087, NYCC-09-0356, NCT00982592

10.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 21 and over
Sponsor: NCI
Protocol IDs: NCI-2011-01454, 8418, UCCRC-8418, CDR0000655378, 09-068, N01CM00071, P30CA014599, N01CM00038, NCT01064622

11.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 21 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: SHH4812g, GS01354, NCT01201915

12.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 3 to 21
Sponsor: NCI
Protocol IDs: NCI-2011-02546, CDR0000688451, PBTC-032, U01CA081457, NCT01239316

13.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2011-02564, CDR0000691728, IB-CHONDROG, 8408, NCI-8408-CHONDROG, NCT01267955

14.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 to 75
Sponsor: Other
Protocol IDs: 2011-077, ML28244, NCT01556009

15.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 3 to 21
Sponsor: NCI
Protocol IDs: NCI-2009-01180, CDR0000631677, PBTC-025, U01CA081457, NCT00822458

16.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Pharmaceutical / Industry
Protocol IDs: CDR0000585468, JHOC-J06131, GENETECH-SHH3925g, J06131, NCT00607724

17.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2011-01400, CDR0000638302, MAYO-MC0811, MC0811, 8231, P30CA015083, U01CA069912, NCT00878163

18.

Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: SHH4610g, NCT00968981

19.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2012-02064, CDR0000662081, 2009-099, 8420, U01CA062487, U01CA070095, P30CA022453, WSU-2009-099, NCT01071564

20.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: SHH4593g, GO01353, NCT01209143

21.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2012-02914, NA_00040967, JHOC-J1067, CDR0000691708, J1067, 8414, U01CA070095, P30CA006973, NCT01330173

22.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: GP27839, NCT01546519

23.

Phase: No phase specified
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2011-03746, UMCC 2010-003, 8417, P30CA046592, 2010-003, NCT01143415, NCT01195415

24.

Phase: No phase specified
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 19 and over
Sponsor: NCI
Protocol IDs: NCI-2012-03099, NCI 8395, 09-149-B, 8395, P30CA014599, U01CA069852, NCT01174264

25.

Phase: No phase specified
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: SKIN0012, NCI-2012-01055, 24313, NCT01631331
New Search